Table 3.
Outcome | Nutritional or Active Vitamin D | Proposed Mechanism | Level of Evidence | References |
---|---|---|---|---|
PTH suppression | A, maybe N | Direct suppression of parathyroid gland | A: RCT | 13,14 |
N: limited RCTs | 15,66 | |||
Reduction of albuminuria | A, maybe N | Suppression of renin-angiotensin system | A: RCT | 59 |
N: limited RCTs | 61 | |||
Reduced risk of infections | N | Increase in cathelicidin levels | Observational studies in general population only | 32,33 |
Reduction of BP | A, maybe N | Suppression of renin-angiotensin system | A: RCT | 59 |
Progression of kidney disease | A, maybe N | Suppression of renin-angiotensin system | A: Observational studies only | 51,52 |
N: low levels associated with outcome | 38,46 | |||
Cardiovascular effects (left ventricular hypertrophy and vascular calcification) | A | Suppression of renin-angiotensin system, possibly direct effects on myocytes | Animal studies | 20 |
Mortality | A | Likely multiple mechanisms | Observational studies only | 6,7,48 |
PTH, parathyroid hormone; A, active; N, nutritional; RCT, randomized controlled trial.